Research Tracker · evidence-gap maps

Evidence-gap maps

110 conditions, updated 2026-11-16.

  1. Research Tracker
  2. Evidence-gap maps

For each condition, a matrix of non-drug approaches against the outcomes trials have measured. Empty cells show where no matching trial was found among those searched, and weak cells where trials have posted no results. Built from 19,258 ClinicalTrials.gov records.

⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

ConditionTrialsResults postedTop possible gap
Acne Vulgaris463–
Age-Related Macular Degeneration8710Among the 30 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (6 trials of other approaches did).
Alcohol Abuse26259Among the 23 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (11 trials of other approaches did).
Alopecia Areata320Among the 13 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (5 trials of other approaches did).
Alpha-1 Antitrypsin Deficiency20–
Alzheimer's Disease and Other Dementias146–
Amyotrophic Lateral Sclerosis9412Among the 10 trials of breathing and respiratory training found, none used symptom severity and disease activity as a primary outcome (22 trials of other approaches did).
Ankylosing Spondylitis571–
Anxiety58917not shown: search capped
Asthma46278not shown: search capped
Atopic Eczema1122Among the 10 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (12 trials of other approaches did).
Atrial Fibrillation14815not shown: search capped
Attention Deficit-Hyperactivity Disorder47548not shown: search capped
autoimmune gastritis00–
Benign Prostatic Hyperplasia392–
Beta Thalassemia231–
Bipolar Disorder47373Among the 13 trials of care delivery and health services found, none used cognition as a primary outcome (58 trials of other approaches did).
Bladder Cancer12317Among the 15 trials of exercise and physical activity found, none used symptom severity and disease activity as a primary outcome (17 trials of other approaches did).
Breast Cancer49855not shown: search capped
Cancer31833not shown: search capped
Carpal Tunnel Syndrome1462Among the 26 trials of rehabilitation and therapy services found, none used inflammation and other biomarkers as a primary outcome (9 trials of other approaches did).
Celiac Disease886Among the 39 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (7 trials of other approaches did).
Cervical Cancer28922not shown: search capped
Chronic Kidney Disease38653not shown: search capped
Chronic Lymphocytic Leukemia549Among the 11 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (8 trials of other approaches did).
Chronic Obstructive Pulmonary Disease30928not shown: search capped
Chronic Pancreatitis283–
Chronic Spontaneous Urticaria50–
Chronic Venous Insufficiency306–
Colorectal Cancer38930not shown: search capped
Cystic Fibrosis20216Among the 19 trials of mind-body and psychological approaches found, none used inflammation and other biomarkers as a primary outcome (30 trials of other approaches did).
Dermatomyositis90–
Diabetic Neuropathy29917not shown: search capped
Endometriosis1035Among the 12 trials of supplements and nutraceuticals found, none used symptom severity and disease activity as a primary outcome (17 trials of other approaches did).
Epilepsy34928Among the 30 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (54 trials of other approaches did).
Essential Hypertension781Among the 18 trials of cognitive training and education found, none used physical function and exercise capacity as a primary outcome (3 trials of other approaches did).
Fibromyalgia47426Among the 9 trials of breathing and respiratory training found, none used symptom severity and disease activity as a primary outcome (74 trials of other approaches did).
Gastroesophageal Reflux Disease962Among the 12 trials of oxygen, light, temperature and manual therapies found, none used quality of life as a primary outcome (14 trials of other approaches did).
Gastroparesis275–
Glaucoma11713Among the 23 trials of supplements and nutraceuticals found, none used quality of life as a primary outcome (8 trials of other approaches did).
Gout327Among the 8 trials of supplements and nutraceuticals found, none used pain as a primary outcome (4 trials of other approaches did).
Gulf War Illness2611–
Heart Failure36427not shown: search capped
Hemophilia432Among the 11 trials of oxygen, light, temperature and manual therapies found, none used symptom severity and disease activity as a primary outcome (5 trials of other approaches did).
Hepatitis B476Among the 8 trials of cognitive training and education found, none used clinical events, survival and healthcare use as a primary outcome (7 trials of other approaches did).
Hepatitis C14826Among the 21 trials of supplements and nutraceuticals found, none used symptom severity and disease activity as a primary outcome (12 trials of other approaches did).
HIV/AIDS627131not shown: search capped
Huntington Disease395Among the 11 trials of supplements and nutraceuticals found, none used cognition as a primary outcome (4 trials of other approaches did).
Hypothyroidism190–
Immune Thrombocytopenia30–
Inflammatory Bowel Disease24911not shown: search capped
Insomnia34524not shown: search capped
Interstitial Cystitis306Among the 9 trials of oxygen, light, temperature and manual therapies found, none used inflammation and other biomarkers as a primary outcome (3 trials of other approaches did).
Irritable Bowel Syndrome38218Among the 17 trials of oxygen, light, temperature and manual therapies found, none used inflammation and other biomarkers as a primary outcome (43 trials of other approaches did).
Ischemic Stroke29721not shown: search capped
Kidney Stones8311Among the 8 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (11 trials of other approaches did).
Long COVID24313Among the 27 trials of oxygen, light, temperature and manual therapies found, none used breathing and lung function as a primary outcome (28 trials of other approaches did).
Low Back Pain63627not shown: search capped
Lung Cancer31534not shown: search capped
Lupus Nephritis40–
Lyme Disease114–
Lyme disease and post-treatment Lyme disease syndrome114–
Major Depressive Disorder59060not shown: search capped
Mast Cell Activation Syndrome62–
Mast Cell Activation Syndrome10–
Mastocytosis with KIT D816V Mutation00–
Measles101–
Melanoma13324Among the 10 trials of oxygen, light, temperature and manual therapies found, none used inflammation and other biomarkers as a primary outcome (19 trials of other approaches did).
Metabolic Dysfunction-Associated Steatohepatitis381–
Migraine Disorder31533Among the 13 trials of diet, fasting and nutrition found, none used physical function and exercise capacity as a primary outcome (55 trials of other approaches did).
Multiple Myeloma16220Among the 26 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (19 trials of other approaches did).
Multiple Sclerosis60745not shown: search capped
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome633Among the 12 trials of oxygen, light, temperature and manual therapies found, none used physical function and exercise capacity as a primary outcome (11 trials of other approaches did).
Myasthenia Gravis221Among the 12 trials of exercise and physical activity found, none used mood, anxiety and wellbeing as a primary outcome (3 trials of other approaches did).
Myelodysplastic Syndrome536Among the 9 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (8 trials of other approaches did).
Non-Hodgkin Lymphoma8316not shown: search capped
Obesity66862not shown: search capped
Obstructive Sleep Apnea47362not shown: search capped
Opioid Use Disorder456101Among the 27 trials of care delivery and health services found, none used pain as a primary outcome (47 trials of other approaches did).
Osteoarthritis37220not shown: search capped
Osteoporosis34450Among the 18 trials of diet, fasting and nutrition found, none used clinical events, survival and healthcare use as a primary outcome (29 trials of other approaches did).
Ovarian Cancer23525not shown: search capped
Overactive Bladder12311Among the 8 trials of supplements and nutraceuticals found, none used quality of life as a primary outcome (11 trials of other approaches did).
Pancreatic Cancer18223not shown: search capped
Parkinson Disease49046not shown: search capped
Peripheral Arterial Disease21935not shown: search capped
Polycystic Kidney Disease233–
Polycystic Ovary Syndrome24413Among the 28 trials of oxygen, light, temperature and manual therapies found, none used cognition as a primary outcome (14 trials of other approaches did).
Polycythemia Vera70–
Post-Acute COVID/Vaccination Syndrome30–
Postural Orthostatic Tachycardia Syndrome365–
Primary Sclerosing Cholangitis81–
Prostate Cancer30536not shown: search capped
Psoriasis Vulgaris142–
Psoriatic Arthritis400Among the 8 trials of cognitive training and education found, none used physical function and exercise capacity as a primary outcome (8 trials of other approaches did).
Pulmonary Arterial Hypertension17316Among the 13 trials of rehabilitation and therapy services found, none used heart rate, blood pressure and autonomic as a primary outcome (39 trials of other approaches did).
Restless Legs Syndrome574–
Rheumatoid Arthritis32140Among the 10 trials of rehabilitation and therapy services found, none used physical function and exercise capacity as a primary outcome (59 trials of other approaches did).
Sarcopenia54426Among the 12 trials of oxygen, light, temperature and manual therapies found, none used weight and metabolic markers as a primary outcome (87 trials of other approaches did).
Schizophrenia53959not shown: search capped
Sepsis14413not shown: search capped
Sickle Cell Disease17136Among the 24 trials of supplements and nutraceuticals found, none used pain as a primary outcome (43 trials of other approaches did).
Sjögren's Syndrome130–
Systemic Lupus Erythematosus11516Among the 17 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (16 trials of other approaches did).
Thyroid Cancer678Among the 8 trials of exercise and physical activity found, none used mood, anxiety and wellbeing as a primary outcome (13 trials of other approaches did).
Tinnitus15823Among the 17 trials of oxygen, light, temperature and manual therapies found, none used mood, anxiety and wellbeing as a primary outcome (18 trials of other approaches did).
Type 1 Diabetes Mellitus48089not shown: search capped
Type 2 Diabetes Mellitus67761not shown: search capped
Venous Thromboembolism305–
Vitiligo235–

Method: how trials are selected. A gap means no matching trial was found among those searched, not that an approach would work.